Close

Analyst Ratings for Pernix Therapeutics (PTX) [Neutrals]

PTX Rating Summary

  |   Expand Research on PTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4 / 10   Percentile Rank: 58%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/12/2016 Brean Capital N/A Downgrade Hold
(Buy)
N/A
(N/A)
0.76
(0.21)
-72.37% Details
3/17/2016 Oppenheimer N/A Downgrade Perform
(Outperform)
N/A
(N/A)
1.16
(0.21)
-81.9% Details